Gene Expression Profiling of Immune-Competent Human Cells Exposed to Engineered Zinc Oxide or Titanium Dioxide Nanoparticles

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Tuomela, Soile ^a,b   Autio, Reija ^a,c   Buerki Thurnherr, Tina ^d   Arslan, Osman ^e   Kunzmann, Andrea ^f   Andersson Willman, Britta ^f   Wick, Peter ^d   Mathur, Sanjay ^e   Scheynius, Annika ^f   Krug, Harald F ^d   Fadeel, Bengt ^f   Lahesmaa, Riitta ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b Turku Doctoral Programme of Biomedical Sciences   (Finland)

^c TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^d SWISS FEDERAL LABORATORIES FOR MATERIALS SCIENCE AND TECHNOLOGY   (Switzerland)

^e UNIVERSITY OF COLOGNE   (Germany)

^f KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

METALLOTHIONEIN; NANOPARTICLE; TITANIUM DIOXIDE; ZINC OXIDE;

ARTICLE; BIOINFORMATICS; CELL DEATH; CELL FUNCTION; CELL GROWTH; CELL TYPE; DENDRITIC CELL; DISSOLUTION; GENE EXPRESSION PROFILING; GENETIC ANALYSIS; GENETIC REGULATION; HUMAN; HUMAN CELL; IMMUNOCOMPETENCE; IMMUNOCYTOTOXICITY; IMMUNOMODULATION; LEACHING; LEUKEMIA CELL LINE; MACROPHAGE; MONOCYTE; NANOENGINEERING; TRANSCRIPTOMICS; UPREGULATION;

ADULT; COMPUTATIONAL BIOLOGY; DENDRITIC CELLS; ENGINEERING; GENE EXPRESSION PROFILING; HUMANS; JURKAT CELLS; MACROPHAGES; MONOCYTES; NANOPARTICLES; NANOTECHNOLOGY; TITANIUM; TRANSCRIPTION, GENETIC; ZINC OXIDE;

EID: 84880671206     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0068415     Document Type: Article

References (59)

1. Shvedova AA, Kagan VE, Fadeel B, (2010) Close encounters of the small kind: Adverse effects of man-made materials interfacing with the nano-cosmos of biological systems. Annu Rev Pharmacol Toxicol 50: 63-88.
2. Iavicoli I, Leso V, Fontana L, Bergamaschi A, (2011) Toxicological effects of titanium dioxide nanoparticles: A review of in vitro mammalian studies. Eur Rev Med Pharmacol Sci 15: 481-508.
3. Schilling K, Bradford B, Castelli D, Dufour E, Nash JF, et al. (2010) Human safety review of "nano" titanium dioxide and zinc oxide. Photochem Photobiol Sci 9: 495-509.
4. Landsiedel R, Kapp MD, Schulz M, Wiench K, Oesch F, (2009) Genotoxicity investigations on nanomaterials: Methods, preparation and characterization of test material, potential artifacts and limitations - many questions, some answers. Mutat Res 681: 241-258.
5. Krug HF, Wick P, (2011) Nanotoxicology: An interdisciplinary challenge. Angew Chem Int Ed Engl 50: 1260-1278.
6. Fedulov AV, Leme A, Yang Z, Dahl M, Lim R, et al. (2008) Pulmonary exposure to particles during pregnancy causes increased neonatal asthma susceptibility. Am J Respir Cell Mol Biol 38: 57-67.
7. Buerki-Thurnherr T, Xiao L, Diener L, Arslan O, Hirsch C, et al. (2013) In vitro mechanistic study towards a better understanding of ZnO nanoparticle toxicity. Nanotoxicology 7: 402-416.
8. Xia T, Kovochich M, Liong M, Madler L, Gilbert B, et al. (2008) Comparison of the mechanism of toxicity of zinc oxide and cerium oxide nanoparticles based on dissolution and oxidative stress properties. ACS Nano 2: 2121-2134.
9. Shi J, Karlsson HL, Johansson K, Gogvadze V, Xiao L, et al. (2012) Microsomal glutathione transferase 1 protects against toxicity induced by silica nanoparticles but not by zinc oxide nanoparticles. ACS Nano 6: 1925-1938.
10. Moos PJ, Olszewski K, Honeggar M, Cassidy P, Leachman S, et al. (2011) Responses of human cells to ZnO nanoparticles: A gene transcription study. Metallomics 3: 1199-1211.
11. Cho WS, Duffin R, Poland CA, Duschl A, Oostingh GJ, et al. (2012) Differential pro-inflammatory effects of metal oxide nanoparticles and their soluble ions in vitro and in vivo; zinc and copper nanoparticles, but not their ions, recruit eosinophils to the lungs. Nanotoxicology 6: 22-35.
12. Reyes VC, Li M, Hoek EM, Mahendra S, Damoiseaux R, (2012) Genome-wide assessment in escherichia coli reveals time-dependent nanotoxicity paradigms. ACS Nano 6: 9402-9415.
13. Lin W, Xu Y, Huang C-, Ma Y, Shannon KB, et al. (2009) Toxicity of nano- and micro-sized ZnO particles in human lung epithelial cells. J Nanopart Res 11: 25-25-39.
14. Andreini C, Banci L, Bertini I, Rosato A, (2006) Counting the zinc-proteins encoded in the human genome. J Proteome Res 5: 196-201.
15. Tupler R, Perini G, Green MR, (2001) Expressing the human genome. Nature 409: 832-833.
16. Hussain S, Vanoirbeek JA, Hoet PH, (2012) Interactions of nanomaterials with the immune system. Wiley Interdiscip Rev Nanomed Nanobiotechnol 4: 169-183.
17. Kunzmann A, Andersson B, Thurnherr T, Krug H, Scheynius A, et al. (2011) Toxicology of engineered nanomaterials: Focus on biocompatibility, biodistribution and biodegradation. Biochim Biophys Acta 1810: 361-373.
18. Damoiseaux R, George S, Li M, Pokhrel S, Ji Z, et al. (2011) No time to lose - high throughput screening to assess nanomaterial safety. Nanoscale 3: 1345-1360.
19. Pacholski C, Kornowski A, Weller H, (2002) Self-assembly of ZnO: From nanodots to nanorods. Angew Chem Int Ed Engl 41: 1188-1191.
20. Mudunkotuwa IA, Rupasinghe T, Wu CM, Grassian VH, (2012) Dissolution of ZnO nanoparticles at circumneutral pH: A study of size effects in the presence and absence of citric acid. Langmuir 28: 396-403.
21. Palomäki J, Karisola P, Pylkkänen L, Savolainen K, Alenius H, (2010) Engineered nanomaterials cause cytotoxicity and activation on mouse antigen presenting cells. Toxicology 267: 125-131.
22. Smyth GK, Michaud J, Scott HS, (2005) Use of within-array replicate spots for assessing differential expression in microarray experiments. Bioinformatics 21: 2067-2075.
23. Andersson-Willman B, Gehrmann U, Cansu Z, Buerki-Thurnherr T, Krug H, et al. (2012) Effects of subtoxic concentrations of TiO(2) and ZnO nanoparticles on human lymphocytes, dendritic cells and exosome production. Toxicol Appl Pharmacol 264: 94-94-103.
24. Sullivan VK, Cousins RJ, (1997) Competitive reverse transcriptase-polymerase chain reaction shows that dietary zinc supplementation in humans increases monocyte metallothionein mRNA levels. J Nutr 127: 694-698.
25. Sullivan VK, Burnett FR, Cousins RJ, (1998) Metallothionein expression is increased in monocytes and erythrocytes of young men during zinc supplementation. J Nutr 128: 707-713.
26. Sutherland DE, Stillman MJ, (2011) The "magic numbers" of metallothionein. Metallomics 3: 444-463.
27. Sugiura T, Kuroda E, Yamashita U, (2004) Dysfunction of macrophages in metallothionein-knock out mice. J UOEH 26: 193-205.
28. Cousins RJ, Blanchard RK, Popp MP, Liu L, Cao J, et al. (2003) A global view of the selectivity of zinc deprivation and excess on genes expressed in human THP-1 mononuclear cells. Proc Natl Acad Sci U S A 100: 6952-6957.
29. Lin SF, Wei H, Maeder D, Franklin RB, Feng P, (2009) Profiling of zinc-altered gene expression in human prostate normal vs. cancer cells: A time course study. J Nutr Biochem 20: 1000-1012.
30. Beyerle A, Irmler M, Beckers J, Kissel T, Stoeger T, (2010) Toxicity pathway focused gene expression profiling of PEI-based polymers for pulmonary applications. Mol Pharm 7: 727-737.
31. Liuzzi JP, Cousins RJ, (2004) Mammalian zinc transporters. Annu Rev Nutr 24: 151-172.
32. Overbeck S, Uciechowski P, Ackland ML, Ford D, Rink L, (2008) Intracellular zinc homeostasis in leukocyte subsets is regulated by different expression of zinc exporters ZnT-1 to ZnT-9. J Leukoc Biol 83: 368-380.
33. Hershfinkel M, Moran A, Grossman N, Sekler I, (2001) A zinc-sensing receptor triggers the release of intracellular Ca2+ and regulates ion transport. Proc Natl Acad Sci U S A 98: 11749-11754.
34. Aydemir TB, Blanchard RK, Cousins RJ, (2006) Zinc supplementation of young men alters metallothionein, zinc transporter, and cytokine gene expression in leukocyte populations. Proc Natl Acad Sci U S A 103: 1699-1704.
35. Walter P, Ron D, (2011) The unfolded protein response: From stress pathway to homeostatic regulation. Science 334: 1081-1086.
36. Park SG, Schimmel P, Kim S, (2008) Aminoacyl tRNA synthetases and their connections to disease. Proc Natl Acad Sci U S A 105: 11043-11049.
37. Herold MJ, McPherson KG, Reichardt HM, (2006) Glucocorticoids in T cell apoptosis and function. Cell Mol Life Sci 63: 60-72.
38. Smets LA, Salomons G, Van Rooij H, van den Berg J, (1998) Involvement of the glucocorticoid receptor in stress-induced apoptosis of leukemic cells. Leukemia 12: 406-413.
39. Guo L, Lichten LA, Ryu MS, Liuzzi JP, Wang F, et al. (2010) STAT5-glucocorticoid receptor interaction and MTF-1 regulate the expression of ZnT2 (Slc30a2) in pancreatic acinar cells. Proc Natl Acad Sci U S A 107: 2818-2823.
40. Telford WG, Fraker PJ, (1997) Zinc reversibly inhibits steroid binding to murine glucocorticoid receptor. Biochem Biophys Res Commun 238: 86-89.
41. Plum LM, Rink L, Haase H, (2010) The essential toxin: Impact of zinc on human health. Int J Environ Res Public Health 7: 1342-1365.
42. Hanagata N, Zhuang F, Connolly S, Li J, Ogawa N, et al. (2011) Molecular responses of human lung epithelial cells to the toxicity of copper oxide nanoparticles inferred from whole genome expression analysis. ACS Nano 5: 9326-9338.
43. Adhikary S, Eilers M, (2005) Transcriptional regulation and transformation by myc proteins. Nat Rev Mol Cell Biol 6: 635-645.
44. Patel JH, Loboda AP, Showe MK, Showe LC, McMahon SB, (2004) Analysis of genomic targets reveals complex functions of MYC. Nat Rev Cancer 4: 562-568.
45. Kruse JP, Gu W, (2009) Modes of p53 regulation. Cell 137: 609-622.
46. Loh SN, (2010) The missing zinc: p53 misfolding and cancer. Metallomics 2: 442-449.
47. Xia T, Zhao Y, Sager T, George S, Pokhrel S, et al. (2011) Decreased dissolution of ZnO by iron doping yields nanoparticles with reduced toxicity in the rodent lung and zebrafish embryos. ACS Nano 5: 1223-1235.
48. Gilbert B, Fakra SC, Xia T, Pokhrel S, Madler L, et al. (2012) The fate of ZnO nanoparticles administered to human bronchial epithelial cells. ACS Nano 6: 4921-4930.
49. Vallhov H, Qin J, Johansson SM, Ahlborg N, Muhammed MA, et al. (2006) The importance of an endotoxin-free environment during the production of nanoparticles used in medical applications. Nano Lett 6: 1682-1686.
50. Kunzmann A, Andersson B, Vogt C, Feliu N, Ye F, et al. (2011) Efficient internalization of silica-coated iron oxide nanoparticles of different sizes by primary human macrophages and dendritic cells. Toxicol Appl Pharmacol 253: 81-93.
51. Verdugo RA, Deschepper CF, Munoz G, Pomp D, Churchill GA, (2009) Importance of randomization in microarray experimental designs with illumina platforms. Nucleic Acids Res 37: 5610-5618.
52. Du P, Kibbe WA, Lin SM, (2008) Lumi: A pipeline for processing illumina microarray. Bioinformatics 24: 1547-1548.
53. Lin SM, Du P, Huber W, Kibbe WA, (2008) Model-based variance-stabilizing transformation for illumina microarray data. Nucleic Acids Res 36: e11.
54. Bolstad BM, Irizarry RA, Astrand M, Speed TP, (2003) A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19: 185-193.
55. Gautier L, Cope L, Bolstad BM, Irizarry RA, (2004) Affy - analysis of affymetrix GeneChip data at the probe level. Bioinformatics 20: 307-315.
56. Dai M, Wang P, Boyd AD, Kostov G, Athey B, et al. (2005) Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data. Nucleic Acids Res 33: e175.
57. Smyth GK, (2004) Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3: Article3.
58. Hämäläinen HK, Tubman JC, Vikman S, Kyrölä T, Ylikoski E, et al. (2001) Identification and validation of endogenous reference genes for expression profiling of T helper cell differentiation by quantitative real-time RT-PCR. Anal Biochem 299: 63-70.
59. Oliveros JC (2007) VENNY. An interactive tool for comparing lists with Venn Diagrams. Available: http://Bioinfogp.cnb.csic.es/tools/venny/index.html. Accessed 2013.